The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $44.98

Today's change0.00 0.00%
Updated March 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $44.98

Today's change0.00 0.00%
Updated March 27 4:02 PM EDT. Delayed by at least 15 minutes.

HealthSouth Corp closed at (U.S.)$44.98.

Shares have lost 0.71% over the last five days, but sit 4.13% below their 52-week high. This security has outperformed the S&P 500 by 15.53% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $44.98
  • High--
  • Low--
  • Bid / Ask(U.S.) $41.34 / (U.S.) $48.00
  • YTD % change+16.95%
  • Volume0
  • Average volume (10-day)641,589
  • Average volume (1-month)757,965
  • Average volume (3-month)695,007
  • 52-week range(U.S.) $33.05 to (U.S.) $46.92
  • Beta1.57
  • Trailing P/E20.07×
  • P/E 1 year forward19.72×
  • Forward PEG2.38×
  • Indicated annual dividend(U.S.) $0.84
  • Dividend yield1.87%
  • Trailing EPS(U.S.) $2.24
Updated March 27 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.63%

Based on its net profit margin of 11.63%, HealthSouth Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue607589595584
Total other revenue--------
Total revenue607589595584
Gross profit577562567556
Total cost of revenue30272828
Total operating expense510475468467
Selling / general / administrative349332328329
Research & development--------
Depreciation / amortization28272626
Interest expense (income), net operating--------
Unusual expense (income)120-1--
Other operating expenses, total91898685
Operating income97114128116
Interest income (expense), net non-operating-26-28-28-28
Gain (loss) on sale of assets--------
Other--------
Income before tax748813194
Income after tax55669462
Income tax, total19223733
Net income42508347
Total adjustments to net income-2-2-3-2
Net income before extra. items39517947
Minority interest-15-15-15-15
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items38497745
Inc. avail. to common incl. extra. items40488045
Diluted net income44528549
Dilution adjustment4454
Diluted weighted average shares101101101101
Diluted EPS excluding extraordinary itemsvalue per share0.410.530.810.49
Dividends per sharevalue per share0.210.210.180.18
Diluted normalized EPSvalue per share0.500.550.820.49